Frederik J. Beekman
Section Leader Biomedical Imaging at TU-Delft, Founder & CEO of MILabs
Seminar Information
In preclinical research we have dreamed about a 3D magnifying glass that would allow us to e.g. see various cell functions and structures in a dynamic 4D single scan, and map integrated detailed dynamics of e.g. contrast agents, tracers, pharmaceuticals, receptors and indicators of therapy response in tumours. To meet these and many other imaging needs we developed the user friendly fully integrated VECTor-6 imaging platform (WMIC innovation of the Year 2018) comprising: A) down to ~0.1 mm SPECT & 0.55 mm PET resolution, with positron-range free PET for otherwise “difficult isotopes” like 124I, 76Br, 86Y, and 82Rb. B) concurrent sub-mm multi-tracer PET & PET-SPECT C) sub-second dynamic PET & SPECT D) sub-mm resolution imaging of a & b-emitting pharmaceuticals E) ultra-high performance low dose X-ray CT and F) optical tomography (Cherenkov, Fluorescence & Bioluminescence)
In this presentation this highly adaptive and versatile nuclear, optical and structural imaging platform will be explained along with many scientific applications contributed by hundreds of world wide users. Finally the results of translating our nuclear imaging technologies into <3 mm resolution clinical SPECT (G-SPECT, WMIS Innovation of the Year 2015) will be presented.
Prof. Frederik J. Beekman Ph.D. heads the section Radiation, Detection & Medical Imaging at TU Delft University. He co-authored over 150 journal papers and is the inventor on 31 patents. Dr. Beekman was honored with several awards for his contributions to SPECT and PET technology and its application in biomedical research (2013 NWO Physics valorization prize, 2015 & 2018 WMIS Innovation of the year 2015 & 2018, SNMMI 2017 Edward Hoffman Memorial Award). His research interests includes biomedical imaging science, AI and image guided radio(- nuclide)therapy. He is an associate editor of several journals and founder and CEO/CSO of MILabs (www.milabs.com) that develops and markets high performance biomedical imaging systems.